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Abstract
Fear of hypoglycemia is common in parents of young children with type 1 diabetes (T1D), but 
little is known about the specific fears that parents most often experience. Hypoglycemia fear has 
been associated with poorer glycemic control in older children, though not yet studied in a large 
cohort of very young children.
Parents of 549 children <7 years (mean 5.2±1.2 years [19% <3 years]) with a mean diabetes 
duration of 2.4±1.0 years (range 1–6 years) and mean HbA1c 8.2%±1.1% (66±12 mmol/mol) 
registered in the T1D Exchange completed the worry scale of the Hypoglycemia Fear Survey 
modified for parents (HFS-P).
Mean parental fear of hypoglycemia worry score was 36.1±23.1 (possible range 0 to 100), with 
most frequent worries related to the child having a low while asleep and the child not recognizing 
a low. The mean worry score was not associated with the child’s age, glycemic control, or recent 
severe hypoglycemic event. Parental worries about lows while sleeping were significantly higher 
in pump users than non-users (61% vs. 45%; p<0.001), and tended to be higher in CGM users than 
non-users (62% vs. 51%; p=0.02).
The greatest worries of parents of young children with T1D were related to hypoglycemia during 
sleep and other times/circumstances during which it would be difficult to detect hypoglycemia. 
Using advanced diabetes technologies may be an effort to temper fears about hypoglycemia during 
sleep, though the directionality of this relationship is undetermined. Additional studies can clarify 
this association and leverage use of diabetes technologies to improve glycemic control.
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Introduction
One of the ever-present and feared complications of type 1 diabetes (T1D) is severe 
hypoglycemia (SH), which can lead to seizure and loss of consciousness. Fear of 
hypoglycemia is especially common in families of young children with T1D due to the 
challenges parents face in striving to maintain optimal glycemic control during this unique 
developmental stage (1). In addition to unpredictable eating habits, irregular bouts of 
physical activity, and labile behavior, young children have limited ability to communicate 
symptoms of low blood glucose concentrations, and parents often cannot recognize that their 
children’s glucose levels are falling (2). Even in older children, parental detection of 
hypoglycemia is limited (3).
Parental fear of hypoglycemia may interfere with achievement of glycemic treatment targets 
(4), as some families may aim for higher blood glucose levels for their children in order to 
avoid lows, due to concerns about acute and chronic neurologic effects of hypoglycemia. 
Among parents with older children (mean ages 8–10 years) with T1D, greater parental 
worry has been associated with poorer glycemic control (5–7). In contrast, small single-
center studies of parents with younger children (ages 2–8 years) have not identified a 
significant relationship (1, 8), and their smaller size limited generalizability to the broader 
national population of young children with T1D. A clearer understanding of the specific 
fears experienced by parents of young children related to hypoglycemia, and of the 
relationship between these fears and glycemic outcomes, is essential before diabetes 
clinicians and researchers can develop intervention strategies targeting parental fear of 
hypoglycemia.
Characterizing fear of hypoglycemia among parents of young children also is an important 
step towards achieving the more stringent targets for glycemic control that have recently 
been recommended in this young population. Data suggesting that hypoglycemia was 
especially damaging to the developing brain (9, 10) previously led the American Diabetes 
Association to recommend that parents of pre-school children with T1D aim to maintain 
HbA1c between 7.5–8.5% (58–69 mmol/mol) compared to the target HbA1c of <7.5% (<58 
mmol/mol) for adolescents (11). However, recent reports from the Diabetes Research in 
Children Network (DirecNet) have shown that chronic hyperglycemia plays at least as 
important a role in altered brain growth and development as hypoglycemia (12, 13), and 
other studies have not confirmed elevated risk for cognitive dysfunction after SH in children 
(14, 15). Moreover, youth in the T1D Exchange clinic registry (T1D Exchange) with HbA1c 
levels well above the target range have reported the same frequency of hypoglycemia-
induced seizures and loss of consciousness as those with HbA1c levels within the target 
range (16, 17). These data led the American Diabetes Association in 2014 to recommend a 
more stringent HbA1c goal of <7.5% (<58 mmol/mol), and even <7% (<53 mmol/mol) if 
this can be achieved without frequent hypoglycemia, across all age groups, including young 
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children (18). This lower HbA1c target requires parents to aim for lower glucose levels, 
which may trigger more parental worries about hypoglycemia.
This study was undertaken using data from a large registry of individuals with T1D from 
diabetes clinics across the United States to characterize the extent of parental fear of 
hypoglycemia in parents of young children under age 7 with T1D, and to identify its 
associations with demographic and clinical characteristics, including HbA1c and use of 
diabetes management technology. The survey and clinical data were analyzed to test our 
hypotheses that greater parental fear of hypoglycemia would be associated with younger age 
of the child, HbA1c above target range, recent SH, and use of insulin pumps and continuous 
glucose monitoring (CGM). An exploratory aim was to identify the specific areas of greatest 
and least parental fear of hypoglycemia in this young age range. This knowledge is 
necessary to inform future interventions aimed at improving glycemic control in young 
children with T1D while mitigating parental fear of hypoglycemia.
Methods
The T1D Exchange includes 74 endocrinology practices based in the United States, 
including 58 centers serving youth with T1D (19). Each clinic received approval from a 
local institutional review board. Informed consent was obtained according to institutional 
review board requirements. Data on young children were collected for the registry’s central 
database from the participant’s medical record and by having the parent/guardian (hereto 
forward “parent”) of the participant complete a comprehensive questionnaire, as previously 
described (18). This report includes 549 registry participants from 41 sites enrolled from 
February 1, 2015 to May 2, 2016 who were less than age 7 years and had a clinical diagnosis 
of T1D for at least 1 year, whose parent completed a questionnaire including the 
Hypoglycemia Fear Survey (HFS) (7), as well as information on demographic and diabetes 
management characteristics at the time of registry enrollment. Insulin pump and CGM use 
were reported by the parent and confirmed by clinic. The most recent HbA1c measurement 
within 6 months prior to registry enrollment was obtained from the clinic medical record. 
HbA1c values were measured by point-of-care device or local laboratory. Occurrences of SH 
and diabetic ketoacidosis (DKA) during the 3 months prior to enrollment were reported by 
the parent. SH was defined as hypoglycemia resulting in seizure or loss of consciousness. 
The definition of DKA included diagnosis by a clinician and a visit to a hospital, emergency 
room, or other health care facility.
Hypoglycemia Fear Survey for use by parents (HFS-P)
The original HFS (20) was developed by Cox et al. to assess both behaviors and worries 
related to hypoglycemia in adults with T1D. This tool was modified for use by parents/
guardians (HFS-P) of children with T1D (7), and has been shown to be a reliable and valid 
tool (21, 22). The questionnaire provided to parents of youth in this analysis included only 
the worry scale, in which the term “reaction” was modified to “low” and the item on “child 
losing control” was expanded to “child losing control due to low blood sugar”. Parents were 
asked to rate their agreement with 15 statements regarding worries related to hypoglycemia 
using a 0 (never) to 4 (almost always) Likert scale, which was scored for each participant as 
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the mean of all non-missing responses multiplied by 25, for a maximum total score out of 
100. Higher worry scores represent greater fear of hypoglycemia.
Statistical Analyses
The mean worry score was calculated overall and according to various demographic and 
clinical characteristics. Associations between mean HFS-P worry score and each 
demographic and clinical characteristic were assessed using T-tests or the Wilcoxon Rank-
Sum procedure (or Kruskal Wallis if >2 levels) as appropriate. Adjusted linear regression 
models were performed to assess associations between HFS-P worry score and each 
glycemic outcome: HbA1c, occurrence of SH, and occurrence of DKA, separately. The 
demographic and clinical characteristics used to adjust the models were determined by a 
stepwise selection procedure, where any factor with a p-value <0.1 remained in the final 
adjusted model. The associations between worry score and glycemic outcomes were further 
stratified by insulin pump and CGM use.
Parental ratings for each individual item on the HFS-P worry scale were tabulated overall 
and according to age group (≤3 and 4–6 years). Additionally, associations of the most 
frequently reported worry with diabetes management and glycemic outcomes use were 
assessed using chi-square tests. Data analyses were performed using SAS version 9.4 (2011 
SAS Institute Inc., Cary, NC). All p-values were two-sided. Due to multiple comparisons 
only p-values <0.01 were considered statistically significant.
Results
Participant Characteristics
Parents/guardians of 549 children with T1D under age 7 participated in the survey. The 
mean age of the child participants was 5.2±1.2 years (19% <3 years) and mean duration of 
diabetes was 2.4±1.0 years (range 1–6 years). Mean HbA1c was 8.2%±1.1% (66±12 mmol/
mol). Approximately one-third (32%) of the children were current CGM users and more 
than half (58%) were using insulin pumps. Additional cohort characteristics are shown in 
Table 1.
Mean Worry Score
The mean HFS-P worry score was 36.1±23.1. Parents of children ≤3 years did not report 
greater worry than parents of children aged 4–6 years (p=0.47, Table 1). Parental worry was 
slightly higher for children using an insulin pump vs. injections, though this difference was 
not significant (p=0.06, Table 1). No difference in parental worry was observed for children 
using CGM vs. no CGM (p=0.86, Table 1). The mean worry score among parents who 
reported performing blood glucose monitoring ≥6 times per day was higher than those who 
reported checking blood glucose <6 times per day (37.7±23.2 vs. 31.8±22.3; p=0.004).
Worry score and HbA1c were not significantly associated (unadjusted p=0.79, p=0.89 after 
adjusting for gender of the child and frequency of blood glucose monitoring; Table 1). 
Significant associations of the worry scale with HbA1c also were not observed in separate 
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analyses of pump users compared with non-users and of CGM users compared with non-
users.
The mean HFS-P worry score was not significantly greater among parents/guardians of 
children that had at least one SH event (7% of sample) in the past three months compared 
with those who had no SH events in the past three months (adjusted p=0.95; Table 1). 
Similarly, no association was found between worry score and occurrence of a DKA event 
(5% had ≥1 event in the past 3 months, adjusted p=0.71; Table 1). Stratifying these analyses 
by pump use and CGM use did not demonstrate any significant relationship between 
occurrences of SH and DKA and total worry score.
Frequency of Reported Worries
Parents reported most frequently worrying about their child having a low blood glucose 
while asleep and their child not recognizing a low glucose, with 54% and 47% respectively 
reporting feeling worried ‘often’ or ‘almost always’ about these experiences (Table 2). The 
least frequently reported worries involved the child embarrassing themselves, friends, or 
family in social situations and appearing ‘stupid’ or clumsy (Table 2).
Since parents most frequently worried about hypoglycemia during sleep, this most common 
worry was further evaluated as shown in Figure 1. There was not a statistically significant 
difference in frequency of worry about the child having a low while asleep among parents of 
children ≤3 years of age compared with parents of children age 4–6 (p=0.09, Figure 1). 
Parents whose children used an insulin pump worried significantly more often about their 
child having a low while asleep than parents whose children did not use an insulin pump 
(61% of parents of pump users vs. 45% of parents of non-users; p<0.001, Figure 1). There 
were trends towards higher parental worry about lows during sleep among CGM users 
compared with non-users (62% of parents of CGM users vs. 51% of parents of non-users; 
p=0.02) and among parents whose children had no SH event in the past 3 months compared 
with those with at least one event (56% with no event vs. 34% with event; p=0.01, Figure 1). 
No difference in frequency of worry about lows during sleep was seen among parents of 
children with HbA1c below the target versus above the target range, or for those with 
children who had no DKA event versus at least one DKA event in the past three months.
Discussion
Parents of young children with T1D in this large sample reported that they most frequently 
experience fear of hypoglycemia in contexts which may make it difficult for the parent to 
detect hypoglycemia – during sleep and when the child does not recognize he or she is 
having a low. Maintaining higher glucose levels to avoid hypoglycemia is a strategy 
reportedly used by some families in clinical practice to mitigate hypoglycemia fear; however 
our results indicate that fear of hypoglycemia persists regardless of glycemic control.
There are a limited number of studies evaluating fear of hypoglycemia in parents of young 
children with T1D. Patton et al studied parents of 81 children aged 2–8 years diagnosed with 
T1D and found that fear of hypoglycemia was common in parents, and greatest in mothers. 
Similar to our findings, there was no relationship between HbA1c and hypoglycemia fear (1, 
Van Name et al. Page 5
Pediatr Diabetes. Author manuscript; available in PMC 2019 February 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
8). While fear of hypoglycemia has been reported to be associated with worse glycemic 
control in older children and adolescents (5–7), unique characteristics of young children and 
their care may contribute to the lack of association, including the intense monitoring 
practiced by many parents. Thus, while main goals in young children with T1D are 
improving HbA1c and reducing glycemic variability, parental fear of hypoglycemia does not 
seem to be a primary barrier to meeting these goals.
Despite this finding, addressing fear of hypoglycemia is important in the youngest age 
group, especially in relation to parental quality of life. It is not surprising that the most 
frequent hypoglycemia worry in this young age group is related to hypoglycemia during 
sleep (8). Parents have reported that caring for a young child with T1D demands “constant 
vigilance” (23). The overnight time period presents challenges to this concept as constant 
vigilance is more difficult when children are asleep, and attempts to achieve it have 
detrimental effects on parents’ sleep quality (24) and, hence, on quality of life, which may 
lead parents to compensate by targeting a higher blood glucose overnight.
Advancements in diabetes technology may help address some of the difficulties managing 
young children’s diabetes during sleep. Preschool children require higher basal rates of 
insulin in the evening and lower doses after midnight, which can be challenging to achieve 
using insulin injections (25), while insulin pumps can provide small varying doses of basal 
insulin overnight and are associated with a reduced risk of SH in children (26). Insulin pump 
use may also contribute to the marked decrease in SH events in adolescents (27, 28), and SH 
events are no longer associated with achieving HbA1c targets (28). Additionally, CGM 
systems provide real-time as well as retrospective information about glucose levels, alerts 
for low glucose levels, and integrated, sensor-augmented pump systems can automatically 
suspend basal rates if sensor glucose levels reach a pre-determined low threshold. Use of 
these technologies has the potential to alleviate some parental burden such as worry of 
missing nocturnal hypoglycemia and waking to perform blood glucose checks, as well as 
provide data for dose adjustments to optimize overnight control. Indeed, CGM detects 
hypoglycemia more effectively than frequent blood glucose checks in young children (29).
Despite the presumed benefits of insulin pumps and CGM, worries about hypoglycemia 
during sleep were more frequent in parents of children using insulin pumps and tended to be 
higher in those using CGM. A potential explanation is that fear of hypoglycemia may 
motivate some families to use advanced diabetes technologies such as pumps and CGMs. On 
the other hand, heightened awareness of previously unknown glucose excursions, due to use 
of these technologies may also increase parental concerns. A prospective, longitudinal study 
will be necessary to understand the directionality and potential bidirectionality of this 
relationship. Such information would be valuable to inform families of the impact of 
technology use and assist parents in balancing use of diabetes technologies that allow for 
optimal diabetes management while preserving emotional well-being and quality of life.
Addressing fear of hypoglycemia is an important part of clinical care in families of young 
children with T1D. Given consistent high HFS-P worry ratings across groups in this large 
sample, parents’ common concerns about hypoglycemia risks should be addressed at clinical 
visits with young children regardless of the child’s age, glycemic control, treatment regimen, 
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and family’s socioeconomic status. Additionally, the finding of less frequent fear of 
hypoglycemia during sleep in those who report recently experiencing a SH episode is 
surprising and may reflect having surmounted that hurdle, lack of understanding of the 
condition, or may simply be related to the small sample of events during the brief (3 month) 
time frame for SH reporting. Health care providers should understand that this fear is 
common. Empowering families to identify and effectively treat hypoglycemia as well as 
manage their worries with available devices, tools, and strategies has the potential to 
mitigate worry related to hypoglycemia.
Data for this study were collected from the largest published national (US) sample of young 
children under age 7 from multiple diabetes treatment centers in geographically diverse 
areas, which contribute to both the validity and the generalizability of the results. However, 
the T1D exchange clinic registry is not a population based registry. A few limitations must 
be noted when interpreting the results of this study. Given that this study is cross-sectional, 
we cannot draw conclusions about the direction of associations between fear of 
hypoglycemia and the behavioral or clinical variables reported. Thus, we cannot determine 
how or if diabetes technology contributes to or ameliorates the commonly reported fears of 
hypoglycemia or determine whether these fears impact clinical outcomes such as glycemic 
control. Additional limitations include the generalizability to all young populations with 
T1D, given the relatively high average parental educational attainment and income, and 
relatively low racial/ethnic diversity. Gender of the survey respondent (parent) would have 
provided additional insight into interpreting the score, as greater hypoglycemia fear scores 
have been reported in mothers compared with fathers (1, 6).
It is noteworthy that 32% of families of young children in this study were using CGM, 
which is 2–3 fold higher than current CGM use in adolescents and young adults enrolled in 
the T1D Exchange Registry (30). This sharp increase in CGM utilization likely reflects an 
increase in parental and clinician perceptions of the benefits and increased ease of use of 
these devices, alone and in combination with insulin pump therapy. Thus, this may be an 
optimal time to assess how more widespread use of advances in diabetes technology impact 
fear of hypoglycemia in parents of young children with T1D.
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Figure 1. Endorsed Worry about Child having Hypoglycemia while Asleep
Solid black bar represents yes.
Sold white bar represents no.
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Table 1
Mean HFS-P Worry Score According to Demographic and Clinical Characteristics
Mean± SD or N(%) Mean HFS-P Worry Score(mean ± SD) p-value
Child Age in years 0.47
  (mean ± SD) 5.2 ± 1.2
 ≤3 years 102 (19%) 36.7 ± 21.4
 4–6 years 447 (81%) 36.0 ± 23.5
Child Gender 0.04
 Female 254 (46%) 33.7 ± 21.6
 Male 295 (54%) 38.2 ± 24.2
Child Race/Ethnicity 0.21
 White Non-Hispanic 415 (77%) 36.8 ± 22.8
 Black Non-Hispanic 34 (6%) 32.8 ± 25.7
 Hispanic or Latino 55 (10%) 32.5 ± 23.6
 Other 32 (6%) 39.8 ± 26.0
Annual Household Income 0.39
 <$75,000 230 (48%) 38.5 ± 25.6
 ≥$75,000 254 (52%) 35.1 ± 20.6
Highest Level of Parent Education 0.13
 High school/GED or less 219 (41%) 35.7 ± 25.7
 Associate or Bachelor degree 183 (34%) 38.7 ± 22.7
 Master, Professional, or Doctorate degree 137 (25%) 34.1 ± 19.2
Duration of Diabetes in years 0.61
  (mean ± SD) 2.4 ± 1.0
 1–<3 years 409 (74%) 35.8 ± 23.0
 3–<7 years 140 (26%) 37.1 ± 23.4
Reported Frequency of Blood Glucose Monitoring 0.004
  (mean ± SD) 7.1 ± 2.5
 <6 times per day 145 (26%) 31.8 ± 22.3
 ≥6 times per day 404 (74%) 37.7 ± 23.2
Current Pump Use 0.06
 Yes 307 (58%) 36.9 ± 21.8
 No 223 (42%) 34.5 ± 24.8
Current Continuous Glucose Monitor (CGM) Use 0.86
 Yes 173 (32%) 36.1 ± 22.3
 No 376 (68%) 36.2 ± 23.5
Most Recent HbA1c* 0.89
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Mean± SD or N(%) Mean HFS-P Worry Score(mean ± SD) p-value
  (mean ± SD) 8.2% ±1.1%
(66±12 mmol/mol)
 <7.5% (<58 mmol/mol) 133 (25%) 35.0 ± 21.5
 ≥7.5% (≥58 mmol/mol) 405 (75%) 36.5 ± 23.8
Occurrence of ≥1 SH event in past 3 months*,† 0.95
 Yes 38 (7%) 35.3 ± 25.8
 No 511 (93%) 36.2 ± 22.9
Occurrence of ≥1 DKA event in past 3 months*,† 0.71
 Yes 27 (5%) 34.8 ± 23.7
 No 522 (95%) 36.2 ± 23.1
*
P-value from the adjusted model. All models were adjusted for gender and frequency of self-monitoring blood glucose per day
†Occurrence of at least one severe hypoglycemia (SH) event in the past 3 months resulting in seizure or loss of consciousness, and occurrence of at 
least one diabetic ketoacidosis (DKA) event in the past 3 months
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Table 2
Frequent and Infrequent Parental-Reported Worries about their Child and Hypoglycemia
Concern Percent often or almost always worried
Having a low while asleep 54%
Not recognizing/realizing he/she is having a low 47%
Having a low 42%
Developing long-term complications from frequent low blood sugar 31%
Having a low while alone 30%
No one being around to help during a low 30%
Feeling light-headed or faint 23%
Having seizures or convulsions 22%
Not having food, fruit, or juice 22%
Losing control of behavior due to low blood sugar 19%
Feeling dizzy or passing out in public 17%
Getting a bad evaluation at school because of something that happens when sugar is low 14%
Making a mistake or having an accident at school 10%
Embarrassing self or friends/family in social situation 8%
Appearing “stupid” or clumsy 7%
Pediatr Diabetes. Author manuscript; available in PMC 2019 February 01.
